Editorial
doi: 10.1016/j.jacc.2003.08.017.
Peroxisome proliferator-activated receptors as therapeutic targets in inflammation
- PMID: 14642685
- DOI: 10.1016/j.jacc.2003.08.017
Item in Clipboard
Editorial
Peroxisome proliferator-activated receptors as therapeutic targets in inflammation
J Am Coll Cardiol.
.
Free article
No abstract available
Comment on
-
The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients.J Am Coll Cardiol. 2003 Nov 19;42(10):1757-63. doi: 10.1016/j.jacc.2003.04.001. J Am Coll Cardiol. 2003. PMID: 14642684 Clinical Trial.
Similar articles
-
The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients.J Am Coll Cardiol. 2003 Nov 19;42(10):1757-63. doi: 10.1016/j.jacc.2003.04.001. J Am Coll Cardiol. 2003. PMID: 14642684 Clinical Trial.
-
Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting?Clin Cardiol. 2004 Jul;27(7 Suppl 4):IV3-10. doi: 10.1002/clc.4960271603. Clin Cardiol. 2004. PMID: 15470905 Free PMC article. Review.
-
Therapeutic role of peroxisome proliferator-activated receptors in obesity, diabetes and inflammation.Prog Drug Res. 2003;60:93-132. doi: 10.1007/978-3-0348-8012-1_3. Prog Drug Res. 2003. PMID: 12790340 Review.
-
Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators.Circulation. 2000 Jan 25;101(3):235-8. doi: 10.1161/01.cir.101.3.235. Circulation. 2000. PMID: 10645917
-
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.Endocrinology. 1996 Oct;137(10):4189-95. doi: 10.1210/endo.137.10.8828476. Endocrinology. 1996. PMID: 8828476
Cited by
-
The effects of PPARγ on the regulation of the TOMM40-APOE-C1 genes cluster.Biochim Biophys Acta Mol Basis Dis. 2017 Mar;1863(3):810-816. doi: 10.1016/j.bbadis.2017.01.004. Epub 2017 Jan 6. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 28065845 Free PMC article.
-
Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in rats.Br J Pharmacol. 2007 May;151(1):45-53. doi: 10.1038/sj.bjp.0707215. Epub 2007 Mar 12. Br J Pharmacol. 2007. PMID: 17351653 Free PMC article.
-
Inflammation in atherosclerosis and diabetes mellitus.Rev Endocr Metab Disord. 2004 Aug;5(3):255-9. doi: 10.1023/B:REMD.0000032414.17672.5c. Rev Endocr Metab Disord. 2004. PMID: 15211097 Review. No abstract available.
-
Endothelial surface N-glycans mediate monocyte adhesion and are targets for anti-inflammatory effects of peroxisome proliferator-activated receptor γ ligands.J Biol Chem. 2011 Nov 4;286(44):38738-38747. doi: 10.1074/jbc.M111.247981. Epub 2011 Sep 12. J Biol Chem. 2011. PMID: 21911496 Free PMC article.
-
Isoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic Disease.PPAR Res. 2010;2010:153252. doi: 10.1155/2010/153252. Epub 2011 Feb 24. PPAR Res. 2010. PMID: 21461045 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
